Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | MPI | P34949 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | SELL | P14151 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
| ▸ | SELE | P16581 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18523530 | 0.91 | ACHE (0.50) | ACHEERN1ALDH1A1KDM4EMAPT | |
| SCHEMBL16014627 | 0.89 | ACHE (0.48) | ACHEERN1ALDH1A1MAPTGAA | |
| SCHEMBL890499 | 0.87 | ACHE (0.55) | ACHEERN1ALDH1A1KDM4EMAPT | |
| SCHEMBL7520392 | 0.87 | ERN1 (0.57) | ACHEERN1ALDH1A1KDM4EMAPT | |
| SCHEMBL11950304 | 0.85 | ACHE (0.56) | ACHEALDH1A1KDM4EMAPTPOLB | |
| SCHEMBL17431234 | 0.84 | KMT2A (0.42) | ACHEALDH1A1KDM4EMAPTPOLB | |
| SCHEMBL16024769 | 0.82 | TRPA1 (0.46) | ERN1ALDH1A1GAAKMT2ATRPA1 | |
| SCHEMBL16024749 | 0.82 | ALDH1A1 (0.44) | ERN1ALDH1A1MAPTGAARECQL | |
| SCHEMBL16024745 | 0.82 | ERN1 (0.46) | ACHEERN1ALDH1A1KDM4EMAPT | |
| SCHEMBL18826204 | 0.81 | SELL (0.56) | ACHEALDH1A1KDM4EMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3029056-B1 | BIS-PHOSPHITES WITH AN ASYMMETRIC BIARYL CENTRAL COMPONENT | EVONIK DEGUSSA GMBH (DE) | 2018-11-07 | — | — | EP | disclosed |
| EP-3029045-B1 | Bis-phosphites with 2.3 -biphenol unit as central component | EVONIK DEGUSSA GMBH (DE) | 2018-06-13 | — | — | EP | disclosed |
| EP-3029045-B1 | Bis-phosphites with 2.3 -biphenol unit as central component | EVONIK DEGUSSA GMBH (DE) | 2018-06-13 | — | — | EP | disclosed |
| US-9982001-B2 | Bisphosphites having an unsymmetric central biaryl unit | EVONIK DEGUSSA GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| US-9982001-B2 | Bisphosphites having an unsymmetric central biaryl unit | EVONIK DEGUSSA GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| US-9982001-B2 | Bisphosphites having an unsymmetric central biaryl unit | EVONIK DEGUSSA GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| EP-3029050-B1 | Bis-phosphites with a naphthyl-phenyl unit as fin component | EVONIK DEGUSSA GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
| EP-3029050-B1 | Bis-phosphites with a naphthyl-phenyl unit as fin component | EVONIK DEGUSSA GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
| CN-105669758-B | Single phosphite ester with asymmetric biaryl unit | 赢创德固赛有限公司 | 2018-02-13 | — | — | CN | disclosed |
| US-9879353-B2 | Electrochemical coupling of two phenols which differ in their oxidation potential | EVONIK DEGUSSA GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| EP-3029057-A1 | BIS-PHOSPHITES WITH AN ASYMMETRIC BIARYL CENTRAL COMPONENT | Evonik Degussa GmbH (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-3029050-A1 | Bis-phosphites with a naphthyl-phenyl unit as fin component | Evonik Degussa GmbH (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-3029044-A1 | Bis-phosphites with an asymmetric biaryl central component | Evonik Degussa GmbH (DE) | 2016-06-08 | — | — | EP | disclosed |
| US-20160010225-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | EVONIK DEGUSSA GMBH (DE) | 2016-01-14 | — | — | US | disclosed |
| US-20160010225-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | EVONIK DEGUSSA GMBH (DE) | 2016-01-14 | — | — | US | disclosed |
| US-20160010225-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | EVONIK DEGUSSA GMBH (DE) | 2016-01-14 | — | — | US | disclosed |
| EP-2964813-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | Evonik Degussa GmbH (DE) | 2016-01-13 | — | — | EP | disclosed |
| CN-105164318-A | Electrochemical coupling of two phenols which differ in their oxidation potential | EVONIK DEGUSSA GMBH | 2015-12-16 | — | — | CN | disclosed |
| WO-2014135236-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | EVONIK INDUSTRIES AG (DE) | 2014-09-12 | — | — | WO | disclosed |
| WO-2014135236-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | EVONIK INDUSTRIES AG (DE) | 2014-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160010225-A1 | ELECTROCHEMICAL COUPLING OF TWO PHENOLS WHICH DIFFER IN THEIR OXIDATION POTENTIAL | COMT, MT-CO2, CYP11B2 | ACHE 257/4885ERN1 3827/4885ALDH1A1 902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.